Skip to Main Content

An official website of the United States government

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Name Principal Investigator Institution Study Date Approved Project ID
Phase 3 validation of a serum miRNA neural network for early detection of ovarian cancer Kevin Elias Brigham and Women's Hospital PLCO Aug 3, 2017 2017-0023
Phase 3 validation of early detection biomarker panel for pancreatic cancer Ann Oberg Mayo Clinic PLCO Feb 2, 2017 2016-0041
Phase III validation using PLCO specimens of a consensus panel of ovarian cancer biomarkers developed by SPORE/EDRN investigators Daniel W. Cramer Brigham and Women's Hospital / Harvard Medical School PLCO Aug 17, 2005 2005-0009
Phase III validation using PLCO specimens of a consensus panel of ovarian cancer biomarkers developed by SPORE/EDRN investigators: Study 4: Validation using PLCO serial specimens of PLCO Ovarian Cance Nicole Urban Fred Hutchinson Cancer Research Center PLCO Jun 19, 2009 2009-0504
Phenome-Wide Association Studies of the immune-related genetic variants Feng Chen ​Nanjing Medical University PLCO Feb 14, 2023 PLCO-1165
Physical activity and reproductive characteristics in the development of postmenopausal breast cancer Chuanbo Xie Sun Yat-sen University Cancer Center PLCO Jan 10, 2017 PLCO-249
Physical activity, PSA levels, and screen-detected prostate cancers. Yelena Tarasenko Georgia Southern University PLCO Oct 23, 2018 PLCO-415
Phytoestrogen intake and the risk of total and advanced colorectal cancer Michael Reger Ferris State University PLCO Mar 8, 2018 PLCO-353
Phytoestrogen intake and the risk of total and advanced prostate cancer Michael Reger Indiana University - Indianapolis PLCO Oct 17, 2013 PLCO-48
Pilot study of air pollution adducts in PLCO serum samples Katherine McGlynn National Cancer Institute PLCO Feb 2, 2023 2023-9000
Pilot Study of Feasibility and Importance of Evaluating Impact of PLCO Screening on HRQL of Participants Timothy Church University of Minnesota PLCO Jul 1, 2006 2006-0056
Place of birth, race-ethnicity and the risk of colorectal neoplasia Adeyinka Laiyemo NCI, DCP, BRG PLCO Jun 9, 2011 2011-0067
Plant-based diet and the risk of pancreatic cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial Guo-Chao Zhong The Second Affiliated Hospital of Chongqing Medical University PLCO Mar 30, 2021 PLCO-755
PLCO data integration to PD research as control Andrew Singleton National Institute of Aging PLCO Feb 16, 2022 PLCO-914
PLCO Data Modeling as RDF/JSON-LD Jonas De Almeida National Cancer Institute PLCO Oct 29, 2021 PLCO-843
PLCO: Effects of high-dimensional genetic variation (GWAS) on PSA trajectories and their relationship with prostate cancer incidence Grace Hong NCI PLCO May 18, 2021 PLCO-787
PLCO: Evolution of an Epidemiologic Resource and Opportunities for Future Studies Black Amanda NCI PLCO Sep 16, 2015 PLCO-166
PLCO Participant Survey Shannon Pretzel University of Colorado Health Science Center PLCO May 28, 2009 2009-0116
PLCO risk assessment formula Aharona Shuali Nucleix PLCO Jan 15, 2019 PLCO-441
Poly-metabolite score of adherence to the 2018 World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) Cancer Prevention Recommendations in the Interactive Diet and Activity Tracking in AARP (IDATA) Study Erikka Loftfield Erikka Loftfield Cronin IDATA Jun 14, 2024 IDATA-74